Related Experiment Videos
Cancer risk from orthopedic prostheses
1Epidemiology and Vital Statistics, London School of Hygiene and Tropical Medicine, UK.
Annals of Clinical and Laboratory Science
|March 1, 1996
Summary
Hip replacement surgery is common, but metal prostheses may pose long-term cancer risks. Studies show a slight increase in cancer risk, particularly 10+ years post-surgery, warranting further investigation.
Area of Science:
- Orthopedic Surgery
- Oncology
- Biomaterials Science
Background:
- Joint replacement surgeries, particularly hip replacements, have become prevalent over the last 50 years.
- Concerns exist regarding potential long-term adverse effects of metal prostheses, including carcinogenicity due to metal alloy corrosion.
Purpose of the Study:
- To quantitatively assess cancer risk in patients with hip prostheses by combining data from multiple cohort studies.
- To evaluate the association between hip prostheses and the risk of developing various cancers over time.
Main Methods:
- A meta-analysis was conducted on three cohost studies involving 40,945 patients who underwent hip replacement.
- Follow-up duration averaged 8.5 years, with specific analysis for cancer risk within the first 10 years and beyond 10 years post-surgery.
Main Results:
- Overall cancer risk showed a relative risk of 1.02 (95% CI 1.00-1.05).
- An 8% excess of hematopoietic malignancies (leukemia and lymphoma) was observed (RR 1.08, 95% CI 0.97-1.20).
- A borderline statistically significant excess of cancer risk (RR 1.08, 95% CI 1.00-1.13) was noted 10 or more years after surgery.
Conclusions:
- While current results are not alarming, long-term vigilance is necessary due to increasing numbers of patients with prostheses.
- Further large-scale international cohort studies are needed, detailing prosthesis composition and patient exposures, to better quantify risks.
- Investigating metal ion levels and corrosion in relation to cancer development is crucial for future risk assessment.